Glenn Larsen
Direttore/Membro del Consiglio presso ANIKA THERAPEUTICS, INC.
Patrimonio netto: 777 785 $ in data 31/05/2024
Profilo
Glenn R.
Larsen is the founder of Aquinnah Pharmaceuticals, Inc. (founded in 2014) and 180 Therapeutics LP (founded in 2013), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman, respectively.
Currently, he is an Independent Director at Anika Therapeutics, Inc. (since 2015).
Previously, he held Senior Director positions at Genetics Institute LLC (2003-2010) and COO, Director & Executive VP-Development positions at Hydra Biosciences, Inc. (2003-2010).
He was also a Vice President at Wyeth Pharmaceuticals LLC.
From 2010 to 2013, he was the CSO, Executive VP-Research & Development at SpringLeaf Therapeutics, Inc. Dr. Larsen holds a doctorate degree from Stony Brook University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ANIKA THERAPEUTICS, INC.
0.20% | 17/05/2024 | 30 323 ( 0.20% ) | 777 785 $ | 31/05/2024 |
Posizioni attive di Glenn Larsen
Società | Posizione | Inizio |
---|---|---|
ANIKA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 17/02/2015 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Amministratore Delegato | 01/02/2014 |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Fondatore | 01/01/2013 |
Precedenti posizioni note di Glenn Larsen
Società | Posizione | Fine |
---|---|---|
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2010 |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Formazione di Glenn Larsen
Stony Brook University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Retail Trade |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Health Technology |
- Borsa valori
- Insiders
- Glenn Larsen